Healthcare provider profile · identity verified

Gati Niranjan Dhroove, MBBS

Internal Medicine · ST CLOUD, MN · NPI 1982915492

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	718	181
Levothyroxine Sodium	Levothyroxine Sodium	476	109
Amlodipine Besylate	Amlodipine Besylate	423	110
Lisinopril	Lisinopril	345	79
Losartan Potassium	Losartan Potassium	338	100
Omeprazole	Omeprazole	322	96
Metoprolol Succinate	Metoprolol Succinate	288	70
Rosuvastatin Calcium	Rosuvastatin Calcium	286	80
Pantoprazole Sodium	Pantoprazole Sodium	281	69
Simvastatin	Simvastatin	254	67
Sertraline Hcl	Sertraline Hcl	227	57
Trazodone Hcl	Trazodone Hcl	213	56
Famotidine	Famotidine	195	54
Gabapentin	Gabapentin	181	44
Metformin Hcl Er	Metformin Hcl	181	46
Potassium Chloride	Potassium Chloride	171	56
Furosemide	Furosemide	167	51
Hydrochlorothiazide	Hydrochlorothiazide	147	40
Tamsulosin Hcl	Tamsulosin Hcl	135	31
Warfarin Sodium	Warfarin Sodium	135	26
Metoprolol Tartrate	Metoprolol Tartrate	132	34
Metformin Hcl	Metformin Hcl	124	24
Eliquis	Apixaban	119	31
Jardiance	Empagliflozin	118	23
Duloxetine Hcl	Duloxetine Hcl	117	27
Mirtazapine	Mirtazapine	117	35
Alendronate Sodium	Alendronate Sodium	115	36
Allopurinol	Allopurinol	114	28
Finasteride	Finasteride	102	30
Fluticasone Propionate	Fluticasone Propionate	100	32
Pravastatin Sodium	Pravastatin Sodium	86	26
Clopidogrel	Clopidogrel Bisulfate	80	17
Carvedilol	Carvedilol	78	19
Venlafaxine Hcl Er	Venlafaxine Hcl	67	12
Ozempic	Semaglutide	64	suppressed
Citalopram Hbr	Citalopram Hydrobromide	60	22
Buspirone Hcl	Buspirone Hcl	54	17
Glipizide	Glipizide	53	suppressed
Spironolactone	Spironolactone	53	17
Albuterol Sulfate Hfa	Albuterol Sulfate	52	30
Atenolol	Atenolol	52	13
Montelukast Sodium	Montelukast Sodium	52	13
Mounjaro	Tirzepatide	52	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	52	suppressed
Ezetimibe	Ezetimibe	51	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Ropinirole Hcl	Ropinirole Hcl	50	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Xarelto	Rivaroxaban	43	12
Hydralazine Hcl	Hydralazine Hcl	41	15
Bupropion Xl	Bupropion Hcl	37	14
Glipizide Er	Glipizide	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Cephalexin	Cephalexin	31	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	17
Valsartan	Valsartan	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Trulicity	Dulaglutide	27	suppressed
Torsemide	Torsemide	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Azithromycin	Azithromycin	24	20
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Baclofen	Baclofen	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Januvia	Sitagliptin Phosphate	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Cholestyramine	Cholestyramine (With Sugar)	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	13
Temazepam	Temazepam	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Enalapril Maleate	Enalapril Maleate	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Nystatin	Nystatin	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Prednisone	Prednisone	13	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Nystop	Nystatin	12	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Linzess	Linaclotide	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error